• Allritz C., Bette S., Figiel M. and Engele J. (2009) Endothelin-1 reverses the histone deacetylase inhibitor-induced increase in glial glutamate transporter transcription without affecting histone acetylation levels. Neurochem. Int. 55, 2227.
  • Baltan S. (2009) Ischemic injury to white matter: an age-dependent process. Neuroscientist 15, 126133.
  • Baltan S., Besancon E. F., Mbow B., Ye Z., Hamner M. A. and Ransom B. R. (2008) White matter vulnerability to ischemic injury increases with age because of enhanced excitotoxicity. J. Neurosci. 28, 14791489.
  • Baltan S., Bachleda A., Morrison R. S. and Murphy S. P. (2011a) Expression of histone deacetylases in cellular compartments of the mouse brain and the effects of ischemia. Transl. Stroke Res. 2, 411423.
  • Baltan S., Murphy S. P., Danilov C. A., Bachleda A. and Morrison R. S. (2011b) Histone deacetylase inhibitors preserve white matter structure and function during ischemia by conserving ATP and reducing excitotoxicity. J. Neurosci. 31, 39903999.
  • Cummins K. L., Perkel D. H. and Dorfman L. J. (1979) Nerve fiber conduction-velocity distributions. I. Estimation based on the single-fiber and compound action potentials. Electroencephalogr. Clin. Neurophysiol. 46, 634646.
  • Gibson C. L. and Murphy S. P. (2010) Benefits of histone deacetylase inhibitors for acute brain injury: a systematic review of animal studies. J. Neurochem. 115, 806813.
  • Kawahara K., Kosugi T., Tanaka M., Nakajima T. and Yamada T. (2005) Reversed operation of glutamate transporter GLT-1 is crucial to the development of preconditioning-induced ischemic tolerance of neurons in neuron/astrocyte co-cultures. Glia 49, 349359.
  • Kim J. Y., Shen S., Dietz K., He Y., Howell O., Reynolds R. and Casaccia P. (2010) HDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damage. Nat. Neurosci. 13, 180189.
  • Kosugi T., Kawahara K., Yamada T., Nakajima T. and Tanaka M. (2005) Functional significance of the preconditioning-induced down-regulation of glutamate transporter GLT-1 in neuron/astrocyte co-cultures. Neurochem. Res. 30, 11091116.
  • Misgeld T., Kerschensteiner M., Bareyre F. M., Burgess R. W. and Lichtman J. W. (2007) Imaging axonal transport of mitochondria in vivo. Nat. Methods 4, 559561.
  • Morland C., Boldingh K. A., Iversen E. G. and Hassel B. (2004) Valproate is neuroprotective against malonate toxicity in rat striatum: an association with augmentation of high-affinity glutamate uptake. J. Cereb. Blood Flow Metab. 24, 12261234.
  • Romera C., Hurtado O., Botella S. H., Lizasoain I., Cardenas A., Fernandez-Tome P., Leza J. C., Lorenzo P. and Moro M. A. (2004) In vitro ischemic tolerance involves upregulation of glutamate transport partly mediated by the TACE/ADAM17-tumor necrosis factor-alpha pathway. J. Neurosci. 24, 13501357.
  • Stys P. K., Ransom B. R. and Waxman S. G. (1991) Compound action potential of nerve recorded by suction electrode: a theoretical and experimental analysis. Brain Res. 546, 1832.
  • Tekkok S. B., Ye Z. and Ransom B. R. (2007) Excitotoxic mechanisms of ischemic injury in myelinated white matter. J. Cereb. Blood Flow Metab. 27, 15401552.
  • Wu N., Lu X. Q., Yan H. T., Su R. B., Wang J. F., Liu Y., Hu G. and Li J. (2008) Aquaporin 4 deficiency modulates morphine pharmacological actions. Neurosci. Lett. 448, 221225.
  • Zhang M., Li W. B., Geng J. X., Li Q. J., Sun X. C., Xian X. H., Qi J. and Li S. Q. (2007) The upregulation of glial glutamate transporter-1 participates in the induction of brain ischemic tolerance in rats. J. Cereb. Blood Flow Metab. 27, 13521368.